⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14337404 | 1.00 | — | — | |
| SCHEMBL2136690 | 1.00 | — | — | |
| SCHEMBL19788461 | 0.70 | — | — | |
| SCHEMBL19352767 | 0.70 | — | — | |
| SCHEMBL11035819 | 0.69 | — | — | |
| SCHEMBL19150055 | 0.67 | — | — | |
| SCHEMBL6379659 | 0.65 | — | — | |
| SCHEMBL7464658 | 0.65 | — | — | |
| SCHEMBL14641686 | 0.63 | — | — | |
| SCHEMBL1298897 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2890704-B1 | 2'-ETHYNYL NUCLEOSIDE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS | NOVARTIS AG (CH) | 2018-02-28 | — | — | EP | disclosed |